| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.89B | 43.27B | 40.16B | 40.20B | 39.89B | 37.69B |
| Gross Profit | 8.55B | 8.93B | 8.40B | 8.59B | 8.00B | 7.21B |
| EBITDA | 2.54B | 1.94B | 2.00B | 2.41B | 1.74B | 1.22B |
| Net Income | 1.76B | 1.35B | 1.32B | 1.66B | 949.00M | 474.00M |
Balance Sheet | ||||||
| Total Assets | 27.11B | 29.43B | 27.56B | 26.57B | 24.66B | 23.59B |
| Cash, Cash Equivalents and Short-Term Investments | 1.22B | 1.32B | 1.15B | 1.46B | 1.25B | 1.18B |
| Total Debt | 13.70B | 12.01B | 13.47B | 13.82B | 14.64B | 14.91B |
| Total Liabilities | 18.23B | 18.57B | 18.77B | 18.96B | 20.00B | 20.15B |
| Stockholders Equity | 8.88B | 10.86B | 8.79B | 7.61B | 4.65B | 3.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.09B | 588.00M | 1.19B | 538.00M | -1.53B |
| Operating Cash Flow | 0.00 | 1.22B | 662.00M | 1.31B | 598.00M | -1.29B |
| Investing Cash Flow | 0.00 | 681.00M | -5.00M | -84.00M | -70.00M | -264.00M |
| Financing Cash Flow | 0.00 | -1.73B | -1.01B | -1.03B | -484.00M | 1.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥177.28B | 10.76 | ― | 2.66% | -4.58% | 51.25% | |
71 Outperform | ¥224.76B | 18.16 | ― | 3.90% | 1.23% | 11.14% | |
69 Neutral | ¥184.13B | 12.23 | 8.27% | 2.68% | 3.42% | 13.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥4.43B | 9.20 | ― | 2.79% | 4.46% | 21.15% | |
60 Neutral | ¥8.42B | 6.72 | ― | 3.84% | 7.74% | 5.91% | |
57 Neutral | ¥14.14B | 27.32 | ― | 2.41% | -3.10% | 33.69% |